---  
layout: startup_page  
title: "ThirtyFiveBio Limited"  
id: "30fivebio.com"  
permalink: "/thirtyfivebiolimited30fivebio.com04152025/"  
website: "https://30fivebio.com/"  
funding_round: ""  
funding_amount: ""  
investors: "AbbVie Ventures, Canaan, Mayewell Capital"  
about: "ThirtyFiveBio Limited is a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the treatment of gastrointestinal (GI) diseases. The company leverages biomarker-driven precision medicine to target GPR35, aiming to improve disease resolution and remission rates in patients with ulcerative colitis. Their approach focuses on preventing epithelial cell damage and dysfunction, offering a differentiated mechanism compared to existing anti-inflammatory treatments."  
markets: "Biotechnology, Pharmaceuticals, Healthtech"  
hq: "Milton Park, Oxfordshire, United Kingdom"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/thirtyfivebio"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: "https://pitchbook.com/profiles/company/484859-71"  

date_display: "15-Apr-2025"  
date: "2025-04-15"

# SEO Optimization  
meta_title: "ThirtyFiveBio Limited"  
meta_description: "ThirtyFiveBio Limited, ThirtyFiveBio Limited is a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for the ..."  
meta_keywords: "ThirtyFiveBio Limited, Biotechnology, Pharmaceuticals, Healthtech,  funding"  
canonical_url: "https://startup.projectstartups.com/thirtyfivebiolimited30fivebio.com04152025/"  
---